This page is still under construction.
Salmonella is the causative agent for a wide range of diseases in humans, including gastroenteritis and enteric fever. Worldwide, Salmonella is estimated to cause over sixteen million cases of typhoid fever, resulting in approximately six hundred thousand deaths, and over one billion cases of acute gastroenteritis, resulting in approximately three million deaths, each year. Over five hundred genes in Salmonella are directly involved in pathogenesis. Yet, only a subset of these is expressed at a given time. Currently, an integrated model for differential gene expression is lacking. To address this problem, we are investigating how Salmonella dynamically regulates gene expression during the different phases of the infection cycle. By characterizing how these genes are coordinately expressed and regulated, we aim to understand the infection process and, more importantly, discover novel targets for antibiotics.
Role of cross talk in regulating the dynamic expression of the flagellar Salmonella pathogenicity island 1 and type 1 fimbrial genes
Journal of Bacteriology, 192(21):5767-77, 2010
Saini S, Slauch JM, Aldridge PD, Rao CV
The role of coupled positive feedback in the expression of the SPI1 type three secretion system in Salmonella
PLoS Pathogens, 6(7):e1001025, 2010
Saini S, Ellermeier JR, Slauch JM, Rao CV
SprB is the molecular link between Salmonella pathogenicity island 1 (SPI1) and SPI4
Journal of Bacteriology, 192(9):2459-62, 2010
Saini S, Rao CV
The Salmonella SPI1 type three secretion system responds to periplasmic disulfide bond status via the flagellar apparatus and the RcsCDB system
Journal of Bacteriology, 190(1):87-97, 2008
Lin D, Rao CV, Slauch JM
Bacillus subtilis Chemotaxis
We are investigating chemotaxis in the model Gram-positive bacterium Bacillus subtilis. While Escherichia coli has long been the paradigm for bacterial chemotaxis, the pathway architecture is not conserved in other species of bacteria. Interestingly, B. subtilis behaves in an identical manner to E. coli with regards to chemotaxis. The pathways in the two bacteria also have homologous proteins. Yet, how these proteins are “wired” to one another in the two pathways is entirely different. We seek to understand why these two pathways are “wired” differently and the extent of degeneracy in the basic design.
Attractant binding induces distinct structural changes to the polar and lateral signaling clusters in Bacillus subtilis chemotaxis.
Journal of Biological Chemistry, November 2010,
Wu K, Walukiewicz HE, Glekas GD, Ordal GW, Rao CV
Site-specific methylation in Bacillus subtilis chemotaxis: The effect of covalent modifications to the chemotaxis receptor McpB.
Microbiology, September 2010,
Glekas GD, Cates JR, Cohen TM, Rao CV, Ordal GW
A PAS domain binds asparagine in the chemotaxis receptor McpB in Bacillus subtilis
Journal of Biological Chemistry, 285(3):1870-8, 2010
Glekas GD, Foster RM, Cates JR, Estrella JA, Wawrzyniak MJ, Rao CV, Ordal GW
The molecular basis of excitation and adaptation during chemotactic sensory transduction in bacteria
Contributions to Microbiology, 16:33-64, 2009
Rao CV, Ordal GW
The three adaptation systems of Bacillus subtilis chemotaxis
Trends in Microbiology, 16(10):480-7, 2008
Rao CV, Glekas GD, Ordal GW
Phosphatase localization in bacterial chemotaxis: divergent mechanisms, convergent principles
Physical Biology, 14;2(3):148-58, 2005
Rao CV, Kirby JR, Arkin AP
Design and diversity in bacterial chemotaxis: a comparative study in Escherichia coli and Bacillus subtilis
PLoS Biology, 2(2):E49, 2004
Rao CV, Kirby JR, Arkin AP